Advisornet Financial’s Avidity Biosciences RNAM Stock Holding History

Advisornet Financial’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-197	Closed	-$14.2K	–	2348
2025 Q4	$14.2K	Buy	197 +105	+114%	+$6.78K	﹤0.01%	1436
2025 Q3	$4.01K	Buy	92 +45	+96%	+$1.82K	﹤0.01%	1750
2025 Q2	$1.33K	Buy	+47	New	+$1.4K	﹤0.01%	1902

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Advisornet Financial's RNAM Position: Q1 2026 in Review

Advisornet Financial sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 197 shares — an estimated $14.2K sold.

Advisornet Financial first reported a position in RNAM in Q2 2025 and held it in 3 quarters. The position peaked at $14.2K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Advisornet Financial reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Advisornet Financial sold 197 Avidity Biosciences shares in Q1 2026, an estimated $14.2K.
Advisornet Financial first reported a position in Avidity Biosciences in Q2 2025 and held it in 3 quarters.
Advisornet Financial's Avidity Biosciences position peaked at $14.2K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.